[HTML][HTML] Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

B Trujillo, A Wu, D Wetterskog, G Attard - British journal of cancer, 2022 - nature.com
Liquid biopsy has been established as a powerful, minimally invasive, tool to detect clinically
actionable aberrations across numerous cancer types in real-time. With the development of …

[HTML][HTML] Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

B Trujillo, A Wu, D Wetterskog, G Attard - British Journal of Cancer, 2022 - ncbi.nlm.nih.gov
Liquid biopsy has been established as a powerful, minimally invasive, tool to detect clinically
actionable aberrations across numerous cancer types in real-time. With the development of …

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

B Trujillo, A Wu, D Wetterskog… - British Journal of Cancer, 2022 - discovery.ucl.ac.uk
Liquid biopsy has been established as a powerful, minimally invasive, tool to detect clinically
actionable aberrations across numerous cancer types in real-time. With the development of …

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

B Trujillo, A Wu, D Wetterskog… - British journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Liquid biopsy has been established as a powerful, minimally invasive, tool to detect clinically
actionable aberrations across numerous cancer types in real-time. With the development of …

[PDF][PDF] Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges

B Trujillo, A Wu, D Wetterskog… - British Journal of Cancer, 2022 - scienceopen.com
In the UK, prostate cancer is the most common cancer in men with approximately 48,500
cases diagnosed every year. With 11,855 prostate cancer-related deaths annually [1], it is a …

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges.

B Trujillo, A Wu, D Wetterskog, G Attard - British Journal of Cancer, 2022 - europepmc.org
Liquid biopsy has been established as a powerful, minimally invasive, tool to detect clinically
actionable aberrations across numerous cancer types in real-time. With the development of …

Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges.

B Trujillo, A Wu, D Wetterskog, G Attard - British Journal of Cancer, 2022 - europepmc.org
Liquid biopsy has been established as a powerful, minimally invasive, tool to detect clinically
actionable aberrations across numerous cancer types in real-time. With the development of …